Last reviewed · How we verify
CEUS or Contrast enhanced Ultrasound — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
CEUS or Contrast enhanced Ultrasound (CEUS or Contrast enhanced Ultrasound) — Mayo Clinic.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| CEUS or Contrast enhanced Ultrasound TARGET | CEUS or Contrast enhanced Ultrasound | Mayo Clinic | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- CEUS or Contrast enhanced Ultrasound CI watch — RSS
- CEUS or Contrast enhanced Ultrasound CI watch — Atom
- CEUS or Contrast enhanced Ultrasound CI watch — JSON
- CEUS or Contrast enhanced Ultrasound alone — RSS
Cite this brief
Drug Landscape (2026). CEUS or Contrast enhanced Ultrasound — Competitive Intelligence Brief. https://druglandscape.com/ci/ceus-or-contrast-enhanced-ultrasound. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab